Find Federal Grants
National Institutes of Health · PAR-19-367
Health Resources and Services Administration · HRSA-20-021
Stimulating Access to Research in Residency Transition Scholar (StARRTS) (K38) (Clinical Trial Not Allowed)
National Institutes of Health · RFA-HL-20-006
Accelerating the Pace of Drug Abuse Research Using Existing Data (R01 Clinical Trial Optional)
National Institutes of Health · PAR-19-368
Catalyze: Product Definition Device Prototype Design and Testing, Diagnostic Disease Target Identification and Assay Development, and Research Tool Development (R61/R33 - Clinical Trial Not Allowed)
National Institutes of Health · RFA-HL-20-024
Catalyze: Product Definition for Small Molecules and Biologics - Preliminary Product/Lead Series Identification (R33 - Clinical Trial Not Allowed)
National Institutes of Health · RFA-HL-20-027
National Institutes of Health · PAR-19-370
Institutional Research and Academic Career Development Awards (IRACDA) (K12 - Independent Clinical Trial Not Allowed)
National Institutes of Health · PAR-19-366
Using Archived Data and Specimen Collections to Advance Maternal and Pediatric HIV/AIDS Research (R21 Clinical Trial Not Allowed)
National Institutes of Health · RFA-HD-20-020
Revision Applications for Mechanisms of Drug Resistance (U54 Clinical Trials Not Allowed)
National Institutes of Health · RFA-CA-19-051
Prevention of Lower Urinary Tract Symptoms (PLUS) Research Consortium Scientific and Data Coordinating Center (U24 Clinical Trial Optional)
National Institutes of Health · RFA-DK-19-016
Prevention of Lower Urinary Tract Symptoms (PLUS) Research Consortium Clinical Research Centers (U01 Clinical Trial Optional)
National Institutes of Health · RFA-DK-19-015
Revision Applications for Mechanisms of Drug Resistance (P50 Clinical Trials Not Allowed)
National Institutes of Health · RFA-CA-19-053
Revision Applications for Mechanisms of Drug Resistance (P01 Clinical Trials Not Allowed)
National Institutes of Health · RFA-CA-19-052
Revision Applications for Mechanisms of Drug Resistance (U01 Clinical Trials Not Allowed)
National Institutes of Health · RFA-CA-19-050
Revision Applications for Mechanisms of Drug Resistance (R01 Clinical Trials Not Allowed)
National Institutes of Health · RFA-CA-19-049
National Institutes of Health · RFA-NS-20-014
Mechanistic Basis of TDP-43-dependent Pathobiology in Common Dementias (R01 Clinical Trial not Allowed)
National Institutes of Health · RFA-NS-20-005
Integration of Imaging and Fluid-Based Tumor Monitoring in Cancer Therapy (R01 Clinical Trial Optional)
National Institutes of Health · PAR-19-363
Using Longitudinal Data to Characterize the Natural History of Fragile X Syndrome to Improve Services and Outcomes
Centers for Disease Control and Prevention - ERA · RFA-DD-20-001